Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TAZAROTENE, with a corresponding US DMF Number 29600.
Remarkably, this DMF maintains an Active status since its submission on July 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 24, 2017, and payment made on April 03, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II